BCIQ Profiles

Company Profile Report

Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal

With $33 million in new series A funding, a portfolio of preclinical assets from The Medicines Co. (NASDAQ:MDCO) and a BARDA deal, Qpex Biopharma Inc.

Read the full 258 word article

How to gain access

Continue reading with a
two-week free trial.